ideaPoint Announces Integration of Clarivate Analytics’ Cortellis for Enhanced Competitive Insight

Industry leading BioPharma Partnering Software now provides competitive intelligence insight to enhance strategic partnering and accelerate growth

Boston, March 25, 2019

Anaqua, a leading software provider of intellectual property and innovation management solutions, today announced that ideaPoint™ is now enhanced with the integration of content from CortellisTM, a suite of intelligence solutions provided by Clarivate Analytics. Cortellis is designed to unlock hidden insights to enable data-driven decision making across the R&D lifecycle. The integration brings Cortellis Competitive Intelligence to ideaPoint users, supporting faster, more accurate analysis of business development options.

Through this partnership, ideaPoint users can now enhance competitive insight. With a simple click, pharmaceutical and biotechnology companies can unlock the landscape of an opportunity to quickly understand white space or perform a high-level canvas to determine best candidates for Merger & Acquisition or Licensing opportunities. The addition of selected Cortellis content enables users to view comparator deals and discover areas of active partnering activity.

“At Anaqua, we are dedicated to delivering the most sophisticated intelligent data and analytics our clients can leverage to exponentially bring value to their business,” said Bob Romeo, Anaqua CEO. “Integrating Cortellis content within ideaPoint further supports our efforts in making the biopharama industry a more collaborative, efficient space.”

“Organizations looking to get the most value out of their Partnering & Innovation Programs now have the opportunity to enhance their competitive insight by pairing market intelligence directly with a partnering opportunity,” said Scott Shaunessy, ideaPoint CEO. “Partnerships with elite

providers such as Clarivate Analytics demonstrate our commitment to making it easier for the biopharma industry to capitalize on partnering opportunities and increase success across the drug development lifecycle.”

About Clarivate Analytics

Clarivate Analytics is a global leader in providing trusted insights and analytics to accelerate the pace of innovation. Building on a heritage going back more than a century and a half, we have built some of the most trusted brands across the innovation lifecycle, including Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor, and Techstreet. Today, Clarivate Analytics is a new and independent company, on a bold entrepreneurial mission to help our clients radically reduce the time from new ideas to life-changing innovations. For more information, please visit www.clarivate.com.

About Cortellis

Cortellis gives life to science by unlocking the hidden insights in data. This industry-leading solution curates the broadest and deepest sources of intelligence to enable precise, actionable answers to specific questions across the R&D lifecycle — from discovery and clinical development through regulatory submission and commercialization. By supporting data-driven decisions, Cortellis helps pharmaceutical companies, biotech and medical device/diagnostic firms accelerate innovation. In 2017, 80% of U.S. companies filing NMEs, 91% of companies achieving breakthrough therapy status and 70% of the top licensing deals were informed by Cortellis intelligence. To learn more, visit Clarivate.com/Cortellis.

Forward-Looking Statements

This press release and oral statements made with respect to information contained in this release may contain forward-looking statements regarding Clarivate Analytics. Forward-looking statements provide Clarivate Analytics’ current expectations or forecasts of future events and may include statements regarding anticipated synergies and other future expectations. These statements involve risks and uncertainties including factors outside of Clarivate Analytics’ control that may cause actual results to differ materially. Clarivate Analytics undertakes no obligation to update or revise the statements made herein, whether as a result of new information, future events or otherwise.

About Anaqua

Anaqua is a premium provider of integrated, end-to-end innovation and intellectual property (IP) management solutions, serving 50% of the top 25 U.S. patent filers, 50% of the top 25 global brands, and a growing number of the most prestigious, forward-looking law firms. The company’s global operations are headquartered in Boston, with offices across Europe and Asia. Anaqua’s IP platform is used by nearly one million IP executives, attorneys, paralegals, administrators, and innovators globally. Its solution suite merges best practice workflows with big data analytics and tech-enabled services to create one intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations. Anaqua was founded in 2004 to commercialize software developed by corporate IP practitioners from Ford and British American Tobacco, addressing a market need for IP enterprise software. The Company later acquired SGA2 (founded in 1994) to complement its core IP management software with patent annuity and trademark renewal payment services. Since late 2015, Anaqua has accelerated execution of its global growth strategy to acquire and integrate talent, expertise, technology, and data via five acquisitions, including ideaPoint, AcclaimIP, and Lecorpio. For additional information, please visit www.anaqua.com.

Press Contact

Amanda Hollis
Anaqua
Achim von Michel
WORDUP PR
Kyoko Tsurumi (鶴見恭子)
Anaqua